# Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots

> **NCT02752607** · — · TERMINATED · sponsor: **Dr. Vicky Tagalakis** · enrollment: 52 (actual)

## Conditions studied

- Deep Vein Thrombosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02752607
- **Lead sponsor:** Dr. Vicky Tagalakis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2018-11-09
- **Final completion:** 2018-11-09
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** The study was stopped early due to low recruitment
- **Last updated:** 2018-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02752607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02752607, "Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02752607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*